Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate for Radiation Retinopathy
NCT00211367Phase 2Terminated
- Sponsor
- Manhattan Eye, Ear and Throat Hospital
- Start
- Apr 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in radiation retinopathy (RR), sponsored by Manhattan Eye, Ear and Throat Hospital. Started Apr 2004; status: terminated.
02
Drugs
anecortave
03
Conditions
radiation retinopathy (RR)
Beyond the preview
Go deeper on NCT00211367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211367.